Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Varenicline
Varenicline (Chantix) received FDA approval in 2006 as a partial α4β2 nicotinic receptor agonist, offering a middle‑ground approach between nicotine replacement and bupropion. Its mechanism delivers enough receptor activation to ease cravings while antagonizing nicotine’s rewarding effects. The drug quickly became a cornerstone of smoking‑cessation therapy, outperforming many existing options in clinical trials. Derived from the natural alkaloid cytisine, varenicline also demonstrated a viable pathway for cost‑effective synthesis of nicotinic agents.
IDEAYA Biosciences Files NDA for Darovasertib/Crizotinib Under FDA’s RTOR Pathway
IDEAYA Biosciences announced that the FDA has accepted its New Drug Application for the darovasertib‑crizotinib combo under the Real‑Time Oncology Review (RTOR) program. The submission follows Phase 2/3 OptimUM‑02 data showing a 58% drop in disease‑progression risk and a median progression‑free...
Merck Still Sees ‘Compelling’ Outlook for Terns Leukemia Drug
Merck agreed to acquire Terns Pharmaceuticals for $6.7 billion, paying $53 per share, after updated trial data showed its TERN‑701 leukemia drug achieving a major molecular response (MMR) rate north of 50% at 24 weeks. The data suggested TERN‑701 could outperform...
RFK Jr. Appeals Ruling that Wiped Out His Vaccine Advisory Panel
The Trump administration has filed an appeal against a March 16 injunction that halted Health Secretary Robert F. Kennedy Jr.'s controversial overhaul of the CDC’s Advisory Committee on Immunization Practices (ACIP). The judge’s order nullified the appointment of anti‑vaccine allies to the...
UK Sees Six‑fold Surge in Health‑related Workforce Inactivity, Straining Economy
New ONS data shows that long‑term sickness‑related work loss in the UK has risen six‑fold since pre‑COVID, with 2.8 million people now inactive, up 700,000. The trend is driven by mental‑health issues and is prompting Labour and former ministers to call...
Harvard Scientists Unveil First ‘Smell Map’ Using 5.5 Million Neurons
A team at Harvard Medical School has built the world’s first detailed map of olfactory receptors, analyzing more than 5.5 million neurons from over 300 mice. The map shows horizontal stripe patterns rather than random distribution, a discovery that could reshape...
South Korea Clears Curocell's Limcarto‑Joo, First Home‑Grown CAR‑T Therapy
Curocell's Limcarto‑Joo received marketing approval from South Korea's Ministry of Food and Drug Safety, becoming the country's first domestically developed CAR‑T therapy. The treatment targets adult patients with diffuse large B‑cell lymphoma and primary mediastinal B‑cell lymphoma, marking a shift...
Shared Responsibility in Patient Care Needs Boundaries
Physicians often end visits with vague advice such as “call if things get worse,” leaving patients without clear criteria for escalation. Dr. Alan F. Feren argues that shared responsibility in care requires explicit boundaries that define what constitutes worsening symptoms, time...
Regular Sex Is Linked to Fewer Daily Menopause Symptoms, Survey Finds
A cross‑sectional survey of more than 4,000 Japanese women aged 40‑79 found that those who reported sexual intercourse within the past three months experienced fewer daily genitourinary menopause symptoms such as dryness, irritation and pelvic pain. The analysis compared 716...
Other News to Note for April 30, 2026
Chinese biotech companies have reached an inflection point, gaining leverage as co‑dealmakers in cross‑border partnerships, according to multinational executives. Roche announced the discovery of new TREM2 agonist compounds aimed at modulating microglial activity for neurodegenerative diseases. Plasticity launched an advanced...
US Spends $15k, Lives Shorter than Swiss
Per my last post on the insanity of healthcare costs in the USA, we spend more than any other nation per capita (by far). We spend around $15k per person per year. Switzerland spends around $9k (which is also considered relatively...
The Bangui Operation: A Story of Blood, Science and Biomedical Exploitation
In the early 1990s the Pasteur Institute in Bangui ran a covert HIV‑vaccine trial that recruited roughly 3,000 Central African soldiers, extracting over 11,000 blood samples. The research was funded by French institutions and aimed to fast‑track vaccine development at...
Hamamatsu Photonics Expands Intended Use of NanoZoomer® MD Series in Europe to Include Cytology
Hamamatsu Photonics announced that its NanoZoomer MD series is now cleared for cytology slide digitization across Europe. The expansion follows a peer‑reviewed validation study by University College London that proved digital cytology reliable for primary diagnosis. The platform can capture Pap...
Guidance Breakdown: FDA Proposes Pulling Back on Premarket Requirements for NIOSH-Approved Respirators
On April 20, the FDA released draft guidance proposing to deprioritize most pre‑market requirements—registration, listing, 510(k), labeling, MDR, and UDI—for NIOSH‑approved respirators used for medical purposes. The policy would cover surgical N95s, other NIOSH‑approved respirators, and public‑use filtering facepiece respirators, while...
How Advanced Mammography Viewers Are Shaping the Future of Breast Cancer Detection
Advanced mammography viewers are delivering sharper, lower‑noise images that help radiologists spot cancers, especially in dense breast tissue. Yet the industry’s biggest hurdle is integrating these tools into real‑world workflows, where speed, usability, and system compatibility dictate whether improved visuals...
Women Live Longer After TAVR than Men
New research published in Heart, Lung and Circulation shows that women have superior long‑term survival after transcatheter aortic valve replacement (TAVR) compared with men. The analysis of 600 patients treated at a high‑volume Norwegian center between 2012 and 2019 found...
CMS Extends GENEROUS Model Deadline for Pharma and States
The Centers for Medicare & Medicaid Services has pushed back the application deadline for the GENEROUS Model, a program that lets state Medicaid programs buy drugs at prices comparable to those in other nations. Manufacturers now have until June 11 to...
Top 15 Biopharma R&D Players and Late‑Stage Prospects
My annual report on the top 15 R&D players in biopharma is out. It's a beast at some 9000 words, but if you're interested in the top prospects in the late-stage pipeline, I got a bunch for you. The stakes...
Telehealth in Schools: Expanding Student Access in a Hybrid Health Care System
The United States’ clinician shortage is prompting schools to become new hubs for telehealth, offering students direct virtual access to medical and mental‑health providers. Early programs in Texas and North Carolina have shown that school‑based telehealth can lower absenteeism, reduce...
Zealand Pharma and Roche Advance Petrelintide to Phase 3 for Chronic Weight Management
Zealand Pharma and Roche are moving the amylin analog petrelintide into Phase 3 trials to treat chronic overweight and obesity. The drug achieved up to 10.7% mean weight loss in the Phase 2 ZUPREME‑1 study, with tolerability comparable to placebo. A March 2025...
AI App Use Increased Patient Understanding of Skin Conditions
A JAMA Dermatology study examined whether an AI‑powered dermatology app improves patients' grasp of skin conditions. Over 2,300 participants were split into a control group, an AI prototype group, and a “Wizard of Oz” group that received dermatologist‑verified predictions. Users...
Here’s Exactly What to Do If You Had a Bad Night of Sleep, According to Sleep Doctors
Sleep doctors Rachel Salas (Johns Hopkins) and Rebecca Robbins (Harvard) outline how to bounce back after a single night of poor sleep. They stress that occasional sleep loss is normal, but recovery can be accelerated with targeted habits such as...
The AI Toolkit for Advocating for a Loved One in the Hospital (4 Prompts Plus Privacy Rules)
The post introduces a practical AI toolkit that helps non‑clinical family members advocate for hospitalized loved ones. It outlines three privacy rules, three verification rules, and provides four ready‑to‑use AI prompts designed to generate evidence‑based questions for clinicians. The author...
Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations
Merck announced the first patient has been dosed in its global Phase 3 ELOWEN program, testing the oral TLR7/8 inhibitor enpatoran in lupus patients with active skin manifestations. The double‑blind, placebo‑controlled studies—ELOWEN‑1 and ELOWEN‑2—will enroll roughly 200 participants each across 266...
FDA Proposes Excluding Novo, Lilly Weight Loss Drugs From Bulk Compounding List in Win for the Companies
The FDA has proposed removing the active ingredients of Novo Nordisk’s semaglutide and liraglutide and Eli Lilly’s tirzepatide from the bulk‑compounding list used by 503B outsourcing facilities. If the rule is finalized, these high‑demand obesity and diabetes drugs could only be...
Irisin Hormone Reverses Obesity and Insulin Resistance
Irisin, a hormone released by muscle during exercise, reverses obesity and insulin resistance in mice -- without cutting food intake or causing muscle loss. As a medical school professor, I find this striking. We have spent a decade asking how to...
Governor Hochul Announces Launch of New 10-Year Statewide Effort to Assess Gambling Addiction and Behaviors in New York State
Governor Kathy Hochul announced a decade‑long, statewide survey to assess gambling behaviors and problem‑gambling prevalence among New Yorkers aged 18 and older. The New York State Office of Addiction Services and Supports (OASAS) will administer questionnaires, interviews and focus groups,...
Artificial Intelligence in Residency Education and Family Medicine
A 2024 survey revealed that 75% of medical students have had no formal AI training, while two‑thirds of practicing physicians already use AI—a 78% jump from the prior year. Family medicine residency programs are now confronting how to embed AI...
Elevance Health’s Affiliated Health Plans Deliver More Predictable, Lower Healthcare Costs for Small Businesses
Elevance Health’s affiliated plans are tackling rising small‑business health costs with two innovative models: Balanced Funding and Multiple Employer Welfare Arrangements (MEWAs). Balanced Funding guarantees a fixed monthly payment while capping risk, rewarding employers when actual claims fall below expectations....
CGT Global Appoints Charlotte Ivancic to Board of Advisors, Strengthening Strategic Leadership in Cell and Gene Therapy Policy and Market...
CGT Global announced the appointment of Charlotte Ivancic to its Board of Advisors, bringing over 25 years of federal health policy and legislative experience. Ivancic, a partner at FGS Global and former senior aide to Senate Majority Leader Bill Frist,...
What We Know (and Don’t Know) About Peptide Safety
Peptide safety is neither automatically assured by mimicking endogenous hormones nor inherently hazardous because research is incomplete. The risk profile depends on the specific peptide, the depth of clinical evidence, product purity, and real‑world usage conditions. Early‑phase trials provide maximum...
Canada’s Life Sciences Sector Welcomes Federal Economic Update’s Focus on SR&ED Implementation
BIOTECanada welcomed the 2026 Spring Economic Update, which confirms the rollout of SR&ED administrative reforms first announced in Budget 2025. The changes raise the annual expenditure limit and taxable‑capital phase‑out thresholds for the enhanced 35% credit, extend the credit to...
GLP-1s May Prevent Incident AF, Series of Studies Shows
Observational analyses presented at Heart Rhythm 2026 suggest GLP‑1 receptor agonists, including tirzepatide, lower the risk of incident atrial fibrillation by 33%‑47% across diverse patient groups. The benefit appears consistent in individuals with or without diabetes, obesity, and chronic kidney...
Gene Therapy Soon as Routine as Everyday Surgery
Eric Kelsic envisions the future of gene therapy will be viewed in the “the same way that many of us have had some form of surgery at certain points in our life.” As therapies become safer and more effective, the decision...
Should Depression Be on the Same Checklist as Smoking and Diabetes?
A propensity‑matched analysis of 11,570 elective single‑level lumbar fusion patients found that preoperative major depressive disorder (MDD) does not raise reoperation, mortality, or early emergency‑department visits. However, the same cohort showed markedly higher rates of new psychiatric diagnoses, somatic symptom...
Why Blood Pressure Control Starts with Weight Management
The Obesity Medicine Association stresses that obesity is a primary, modifiable driver of hypertension. Clinical data show a 5‑10% reduction in body weight typically lowers systolic pressure by 5‑10 mm Hg, and 50‑75% of obese adults already have elevated blood pressure. The...
AiZtech Labs Launches iSelfie BioSignals in U.S. to Automate Intake and Digital Biomarker Detection
AiZtech Labs has launched iSelfie BioSignals in the United States, a smartphone‑based platform that extracts digital biomarkers from a standard selfie. The system, validated in six studies with over 5,000 participants, measures heart rate, SpO2 and calibrated blood pressure under...
Why Value Alignment Is Becoming Healthcare AI’s Defining Issue
Healthcare leaders are confronting a deeper issue than model accuracy: aligning AI with real‑world care delivery. Panels at a NEJM AI virtual event highlighted that global models often falter without local validation, prompting collaborative governance networks. Companies like Microsoft and...
The Vaccine Skeptic in Trump’s New C.D.C. Leadership Team
President Trump appointed FDA deputy commissioner Dr. Sara Brenner, a self‑described “MAHA mom” and vocal vaccine skeptic, as senior counselor for public health to Health Secretary Robert F. Kennedy Jr. The role, which does not require Senate confirmation, makes her...
AI Success Depends on Engaging Multidisciplinary Champions
At HIMSS26, Dr. Jesse Ehrenfeld, global CMO of Aidoc, emphasized that clinician champions are essential for successful AI adoption in healthcare. While executive sponsorship and IT infrastructure lay the groundwork, frontline physicians drive testing, workflow integration, and real‑world validation. Aidoc’s...
Hormonal Contraception May Increase Complications After ACL Surgery
A retrospective analysis of the TriNetX database presented at the AAOS meeting found that women who used hormonal contraception within 30 days of anterior cruciate ligament (ACL) reconstruction faced markedly higher short‑term complications. Compared with matched controls, contraceptive users were...
Clinician Exhaustion Is the Biggest Barrier to AI Adoption
Clinician exhaustion has emerged as the primary obstacle to widespread AI adoption in healthcare, according to Dr. Jesse Ehrenfeld, Aidoc’s global CMO. While AI promises efficiency, many clinicians view new tools as additional burdens that exacerbate burnout. Vendors are therefore...
He Survived a Misdiagnosis. Then He Built an AI Platform for Clinical Decisions.
Clement Okoh survived a misdiagnosed multiple myeloma and founded Monte Sereno Health in 2021, an AI‑powered healthcare operating system aimed at unifying Africa’s fragmented medical landscape. The platform embeds an AI agent, StarPilot, that offers real‑time decision support, pulls patient...
Normal Bloodwork ≠ Healthy: Most Adults Have Hidden Metabolic Risk
Lie I was taught in medical school: if a patient's standard bloodwork is normal, they're healthy. Reality: only about 7% of American adults are metabolically healthy. The other 93% pass routine labs while quietly drifting toward heart attacks, strokes, dementia, and...
UniQure Pursues UK Approval for Huntington’s Gene Therapy
UniQure, in ‘symbolic’ win, to seek UK approval of Huntington’s gene therapy https://t.co/plxdEw43FD by @Lilah_Alvarado $QURE + 22% #GeneTherapy
Vaccine Injury Compensation: Complex Yet Bipartisan Solution Explained
A+ explanation of the vaccine injury compensation program. (I covered it at the time as a cub reporter on the Hill. Very complicated, very bipartisan, tho)
Pinetree Therapeutics: Promising Biotech Worth Watching
A biotech you need to keep an eye on... Pinetree Therapeutics $AZN https://t.co/wVt9XMcr0Z (disclosure: SAB member)
Insurers Exit ACA Market When Enrollees Get Sicker
Cigna is abandoning the ACA health insurance marketplaces by the end of the year, following in Aetna’s footsteps. Insurers have shown, time and again, they will bail on the ACA market if people are too sick. @TaraBannow reports: https://t.co/kW6Cq06Haa
Trump's Psychedelic Order Preserves FDA Oversight Balance
My op ed in today's @WashPost - "Trump’s executive order on psychedelics strikes a healthy balance: The president preserved the FDA's role, even as some want the agency's gatekeeping dismantled." https://t.co/9hH7kz107J
Doctor Wait Times Rising: Hidden Healthcare Inventory Exposed
In 2007, it took 18 days to see a doctor. Today it's 31. "There is hidden inventory in healthcare." - @oliver_kharraz on why the doctor shortage isn't the whole story. WATCH / LISTEN: Spotify: https://t.co/u05FAZy03v Apple: https://t.co/RZx2r8ixFD Youtube: https://t.co/fr1PiqjSZl